Merkel cell polyomavirus infection and persistence modelled in skin organoids

Tools

Item Type:	Preprint
Title:	Merkel cell polyomavirus infection and persistence modelled in skin organoids
Creators Name:	Albertini, S., Czech-Sioli, M., Guenther, T., Virdi, S., Blümke, P., Röpke, L., Brinschwitz, V., Dandri, M., Allweiss, L., Reimer, R., Schneider, C., Hansen, A., Krasemann, S., Wyler, E., Landthaler, M., Grundhoff, A. and Fischer, N.
Abstract:	Merkel cell polyomavirus (MCPyV) causes most Merkel cell carcinomas (MCC). The virus is one of the few known human tumor viruses, and due to its direct role in this skin cancer development, it is a bona fide model for viral tumorigenesis and tumorigenesis in general. Chronic viruses in humans such as MCPyV are highly adapted to their host and current models to study infection, persistence and pathogenesis are highly limited. We here use an induced pluripotent stem cell (iPSC)-derived hair-bearing skin organoid (SkO) system to demonstrate efficient viral infection, progression and spread of MCPyV. Using bulk-, single cell - and spatial- transcriptomics, combined with immunostaining and nucleic acid hybridization technologies, we show that MCPyV ensures persistence due to a quasi-latency state within the majority of dermal fibroblasts carry the viral genome. Further, we identify the cell type of productive infection with papillary fibroblasts and dermal sheath fibroblasts supporting viral replication and progeny production. Our high-resolution methods demonstrate that the virus in these cells evades the innate immune response, as evidenced by the efficacy of interferon-beta treatment or ruxolitinib, a JAK/STAT inhibitor, in suppressing or stimulating viral replication. We show that iPSC-derived SkOs are able to support infection and long-term persistence of the virus under conditions very similar to those found in humans. Thus, this infection model provides a robust platform for understanding and characterizing the interaction of this virus with the immune system in infection, testing treatment strategies to control reactivation and map processes involved in tumor development.
Source:	bioRxiv
Publisher:	Cold Spring Harbor Laboratory Press
Article Number:	2025.02.11.637697
Date:	12 February 2025
Official Publication:	https://doi.org/10.1101/2025.02.11.637697

Repository Staff Only: item control page